Role of aspartyl-(asparaginyl)-β-hydroxylase mediated notch signaling in cerebellar development and function

Behavioral and Brain Functions

Volumn 6, Issue , 2010, Pages

  Silbermann, Elizabeth ^a   Moskal, Peter ^b   Bowling, Nathaniel ^b   Tong, Ming ^a,c   de la Monte, Suzanne M ^a,c  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID DERIVATIVE; ASPARTYL(ASPARAGINYL)BETA HYDROXYLASE; CYTOSKELETON PROTEIN; JAGGED1; NOTCH RECEPTOR; OXYGENASE; PLASMID DNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR HES 1; UNCLASSIFIED DRUG; ASPARTIC ACID 2 OXOGLUTARATE DEPENDENT DIOXYGENASE; ASPARTIC ACID 2-OXOGLUTARATE-DEPENDENT DIOXYGENASE; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CALCIUM BINDING PROTEIN; HES1 PROTEIN, RAT; HOMEODOMAIN PROTEIN; MEMBRANE PROTEIN; MIXED FUNCTION OXIDASE; NOTCH1 RECEPTOR; SERRATE PROTEINS; SIGNAL PEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN DEVELOPMENT; BRAIN FUNCTION; BRAIN WEIGHT; CEREBELLUM; DOWNSTREAM PROCESSING; GENE EXPRESSION; GENE TARGETING; MOTOR PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; ANIMAL; GENE EXPRESSION REGULATION; GENE TRANSFER; GENETICS; GROWTH, DEVELOPMENT AND AGING; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LONG EVANS RAT; METABOLISM; PHYSIOLOGY; PLASMID; PSYCHOMOTOR PERFORMANCE;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CALCIUM-BINDING PROTEINS; CEREBELLUM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE TRANSFER TECHNIQUES; HOMEODOMAIN PROTEINS; INJECTIONS, INTRAVENTRICULAR; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MIXED FUNCTION OXYGENASES; PLASMIDS; PSYCHOMOTOR PERFORMANCE; RATS; RATS, LONG-EVANS; RECEPTOR, NOTCH1; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 78549248798     PISSN: 17449081     EISSN: None     Source Type: Journal    
DOI: 10.1186/1744-9081-6-68     Document Type: Article

References (54)

1. Jia S, VanDusen WJ, Diehl RE, Kohl NE, Dixon RA, Elliston KO, Stern AM, Friedman PA. cDNA cloning and expression of bovine aspartyl (asparaginyl) beta-hydroxylase. J Biol Chem 1992, 267(20):14322-14327.
2. Lavaissiere L, Jia S, Nishiyama M, de la Monte S, Stern AM, Wands JR, Friedman PA. Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma. J Clin Invest 1996, 98(6):1313-1323. 10.1172/JCI118918, 507557, 8823296.
3. Wang QP, VanDusen WJ, Petroski CJ, Garsky VM, Stern AM, Friedman PA. Bovine liver aspartyl beta-hydroxylase. Purification and characterization. J Biol Chem 1991, 266(21):14004-14010.
4. Jia S, McGinnis K, VanDusen WJ, Burke CJ, Kuo A, Griffin PR, Sardana MK, Elliston KO, Stern AM, Friedman PA. A fully active catalytic domain of bovine aspartyl (asparaginyl) beta-hydroxylase expressed in Escherichia coli: characterization and evidence for the identification of an active-site region in vertebrate alpha-ketoglutarate-dependent dioxygenases. Proc Natl Acad Sci USA 1994, 91(15):7227-7231. 10.1073/pnas.91.15.7227, 44372, 8041771.
5. Dinchuk JE, Henderson NL, Burn TC, Huber R, Ho SP, Link J, O'Neil KT, Focht RJ, Scully MS, Hollis JM, Hollis GF, Friedman PA. Aspartyl beta-hydroxylase (Asph) and an evolutionarily conserved isoform of Asph missing the catalytic domain share exons with junctin. J Biol Chem 2000, 275(50):39543-39554. 10.1074/jbc.M006753200, 10956665.
6. Monkovic DD, VanDusen WJ, Petroski CJ, Garsky VM, Sardana MK, Zavodszky P, Stern AM, Friedman PA. Invertebrate aspartyl/asparaginyl beta-hydroxylase: potential modification of endogenous epidermal growth factor-like modules. Biochem Biophys Res Commun 1992, 189(1):233-241. 10.1016/0006-291X(92)91549-6, 1449478.
7. Dinchuk JE, Focht RJ, Kelley JA, Henderson NL, Zolotarjova NI, Wynn R, Neff NT, Link J, Huber RM, Burn TC, Rupar MJ, Cunningham MR, Selling BH, Ma J, Stern AA, Hollis GF, Stein RB, Friedman PA. Absence of post-translational aspartyl beta-hydroxylation of epidermal growth factor domains in mice leads to developmental defects and an increased incidence of intestinal neoplasia. J Biol Chem 2002, 277(15):12970-12977. 10.1074/jbc.M110389200, 11773073.
8. Christiansen JH, Coles EG, Wilkinson DG. Molecular control of neural crest formation, migration and differentiation. Curr Opin Cell Biol 2000, 12(6):719-724. 10.1016/S0955-0674(00)00158-7, 11063938.
9. Cotter D, Honavar M, Lovestone S, Raymond L, Kerwin R, Anderton B, Everall I. Disturbance of Notch-1 and Wnt signalling proteins in neuroglial balloon cells and abnormal large neurons in focal cortical dysplasia in human cortex. Acta Neuropathol (Berl) 1999, 98(5):465-472.
10. Goldbrunner RH, Bernstein JJ, Tonn JC. ECM-mediated glioma cell invasion. Microsc Res Tech 1998, 43(3):250-257. 10.1002/(SICI)1097-0029(19981101)43:3<250::AID-JEMT7>3.0.CO;2-C, 9840803.
11. Merzak A, Koochekpour S, Pilkington GJ. Adhesion of human glioma cell lines to fibronectin, laminin, vitronectin and collagen I is modulated by gangliosides in vitro. Cell Adhes Commun 1995, 3(1):27-43. 10.3109/15419069509081276, 7749720.
12. Tucker RP, Chiquet-Ehrismann R. Teneurins: a conserved family of transmembrane proteins involved in intercellular signaling during development. Dev Biol 2006, 290(2):237-245. 10.1016/j.ydbio.2005.11.038, 16406038.
13. Lindsell CE, Shawber CJ, Boulter J, Weinmaster G. Jagged: a mammalian ligand that activates Notch1. Cell 1995, 80(6):909-917. 10.1016/0092-8674(95)90294-5, 7697721.
14. de La Coste A, Freitas AA. Notch signaling: distinct ligands induce specific signals during lymphocyte development and maturation. Immunol Lett 2006, 102(1):1-9. 10.1016/j.imlet.2005.06.014, 16140393.
15. Cantarini MC, de la Monte SM, Pang M, Tong M, D'Errico A, Trevisani F, Wands JR. Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms. Hepatology 2006, 44(2):446-457. 10.1002/hep.21272, 16871543.
16. Carter JJ, Tong M, Silbermann E, Lahousse SA, Ding FF, Longato L, Roper N, Wands JR, de la Monte SM. Ethanol impaired neuronal migration is associated with reduced aspartyl-asparaginyl-beta-hydroxylase expression. Acta Neuropathol 2008, 116(3):303-315. 10.1007/s00401-008-0377-z, 18478238.
17. de la Monte SM, Tamaki S, Cantarini MC, Ince N, Wiedmann M, Carter JJ, Lahousse SA, Califano S, Maeda T, Ueno T, D'Errico A, Trevisani F, Wands JR. Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness. J Hepatol 2006, 44(5):971-983. 10.1016/j.jhep.2006.01.038, 16564107.
18. de la Monte SM, Tong M, Carlson RI, Carter JJ, Longato L, Silbermann E, Wands JR. Ethanol inhibition of aspartyl-asparaginyl-beta-hydroxylase in fetal alcohol spectrum disorder: potential link to the impairments in central nervous system neuronal migration. Alcohol 2009, 43(3):225-240. 10.1016/j.alcohol.2008.09.009, 2893031, 19393862.
19. Lahousse SA, Carter JJ, Xu XJ, Wands JR, de la Monte SM. Differential growth factor regulation of aspartyl-(asparaginyl)-beta-hydroxylase family genes in SH-Sy5y human neuroblastoma cells. BMC Cell Biol 2006, 7:41. 10.1186/1471-2121-7-41, 1764734, 17156427.
20. Maeda T, Sepe P, Lahousse S, Tamaki S, Enjoji M, Wands JR, de la Monte SM. Antisense oligodeoxynucleotides directed against aspartyl (asparaginyl) beta-hydroxylase suppress migration of cholangiocarcinoma cells. J Hepatol 2003, 38(5):615-622. 10.1016/S0168-8278(03)00052-7, 12713872.
21. Sepe PS, Lahousse SA, Gemelli B, Chang H, Maeda T, Wands JR, de la Monte SM. Role of the aspartyl-asparaginyl-beta-hydroxylase gene in neuroblastoma cell motility. Lab Invest 2002, 82(7):881-891.
22. de la Monte SM, Ganju N, Tanaka S, Banerjee K, Karl PJ, Brown NV, Wands JR. Differential effects of ethanol on insulin-signaling through the insulin receptor substrate-1. Alcohol Clin Exp Res 1999, 23(5):770-777. 10.1097/00000374-199905000-00002, 10371394.
23. de la Monte SM, Neely TR, Cannon J, Wands JR. Ethanol impairs insulin-stimulated mitochondrial function in cerebellar granule neurons. Cell Mol Life Sci 2001, 58(12-13):1950-1960. 10.1007/PL00000829, 11766890.
24. de la Monte SM, Wands JR. Chronic gestational exposure to ethanol impairs insulin-stimulated survival and mitochondrial function in cerebellar neurons. Cell Mol Life Sci 2002, 59(5):882-893. 10.1007/s00018-002-8475-x, 12088287.
25. Soscia SJ, Tong M, Xu XJ, Cohen AC, Chu J, Wands JR, de la Monte SM. Chronic gestational exposure to ethanol causes insulin and IGF resistance and impairs acetylcholine homeostasis in the brain. Cell Mol Life Sci 2006, 63(17):2039-2056. 10.1007/s00018-006-6208-2, 16909201.
26. Xu J, Yeon JE, Chang H, Tison G, Chen GJ, Wands J, de la Monte S. Ethanol impairs insulin-stimulated neuronal survival in the developing brain: role of PTEN phosphatase. J Biol Chem 2003, 278(29):26929-26937. 10.1074/jbc.M300401200, 12700235.
27. de la Monte SM, Xu XJ, Wands JR. Ethanol inhibits insulin expression and actions in the developing brain. Cell Mol Life Sci 2005, 62(10):1131-1145. 10.1007/s00018-005-4571-z, 15870954.
28. de la Monte SM, Wands JR. Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. J Alzheimers Dis 2005, 7(1):45-61.
29. de la Monte SM, Jhaveri A, Maron BA, Wands JR. Nitric oxide synthase 3-mediated neurodegeneration after intracerebral gene delivery. J Neuropathol Exp Neurol 2007, 66(4):272-283. 10.1097/nen.0b013e318040cfa2, 17413318.
30. Lester-Coll N, Rivera EJ, Soscia SJ, Doiron K, Wands JR, de la Monte SM. Intracerebral streptozotocin model of type 3 diabetes: Relevance to sporadic Alzheimer's disease. J Alzheimers Dis 2006, 9(1):13-33.
31. Hamm RJ, Pike BR, O'Dell DM, Lyeth BG, Jenkins LW. The rotarod test: an evaluation of its effectiveness in assessing motor deficits following traumatic brain injury. J Neurotrauma 1994, 11(2):187-196. 10.1089/neu.1994.11.187, 7932797.
32. Gundogan F, Elwood G, Longato L, Tong M, Feijoo A, Carlson RI, Wands JR, de la Monte SM. Impaired placentation in fetal alcohol syndrome. Placenta 2008, 29(2):148-157. 10.1016/j.placenta.2007.10.002, 2692437, 18054075.
33. Cohen AC, Tong M, Wands JR, de la Monte SM. Insulin and insulin-like growth factor resistance with neurodegeneration in an adult chronic ethanol exposure model. Alcohol Clin Exp Res 2007, 31(9):1558-1573. 10.1111/j.1530-0277.2007.00450.x, 17645580.
34. Heck DH, Zhao Y, Roy S, LeDoux MS, Reiter LT. Analysis of cerebellar function in Ube3a-deficient mice reveals novel genotype-specific behaviors. Hum Mol Genet 2008, 17(14):2181-2189. 10.1093/hmg/ddn117, 2902285, 18413322.
35. de la Monte SM, Tong M, Cohen AC, Sheedy D, Harper C, Wands JR. Insulin and insulin-like growth factor resistance in alcoholic neurodegeneration. Alcohol Clin Exp Res 2008, 32(9):1630-1644. 10.1111/j.1530-0277.2008.00731.x, 18616667.
36. Rivera EJ, Goldin A, Fulmer N, Tavares R, Wands JR, de la Monte SM. Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine. J Alzheimers Dis 2005, 8(3):247-268.
37. Valtorta F, Pennuto M, Bonanomi D, Benfenati F. Synaptophysin: leading actor or walk-on role in synaptic vesicle exocytosis?. Bioessays 2004, 26(4):445-453. 10.1002/bies.20012, 15057942.
38. Kolk SM, Kramer BM, Cornelisse LN, Scheenen WJ, Jenks BG, Roubos EW. Multiple control and dynamic response of the Xenopus melanotrope cell. Comp Biochem Physiol B Biochem Mol Biol 2002, 132(1):257-268. 10.1016/S1096-4959(01)00533-4, 11997227.
39. Masliah E, Terry R. The role of synaptic proteins in the pathogenesis of disorders of the central nervous system. Brain Pathol 1993, 3(1):77-85. 10.1111/j.1750-3639.1993.tb00728.x, 8269086.
40. Hooper C, Tavassoli M, Chapple JP, Uwanogho D, Goodyear R, Melino G, Lovestone S, Killick R. TAp73 isoforms antagonize Notch signalling in SH-SY5Y neuroblastomas and in primary neurones. J Neurochem 2006, 99(3):989-999. 10.1111/j.1471-4159.2006.04142.x, 17076661.
41. Solecki DJ, Liu XL, Tomoda T, Fang Y, Hatten ME. Activated Notch2 signaling inhibits differentiation of cerebellar granule neuron precursors by maintaining proliferation. Neuron 2001, 31(4):557-568. 10.1016/S0896-6273(01)00395-6, 11545715.
42. Iso T, Kedes L, Hamamori Y. HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol 2003, 194(3):237-255. 10.1002/jcp.10208, 12548545.
43. Kopan R, Schroeter EH, Weintraub H, Nye JS. Signal transduction by activated mNotch: importance of proteolytic processing and its regulation by the extracellular domain. Proc Natl Acad Sci USA 1996, 93(4):1683-1688. 10.1073/pnas.93.4.1683, 40002, 8643690.
44. Schroeter EH, Kisslinger JA, Kopan R. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature 1998, 393(6683):382-386. 10.1038/30756, 9620803.
45. Hu QD, Cui XY, Ng YK, Xiao ZC. Axoglial interaction via the notch receptor in oligodendrocyte differentiation. Ann Acad Med Singapore 2004, 33(5):581-588.
46. Tanaka M, Marunouchi T. Immunohistochemical localization of Notch receptors and their ligands in the postnatally developing rat cerebellum. Neurosci Lett 2003, 353(2):87-90. 10.1016/j.neulet.2003.08.080, 14664907.
47. Gaiano N, Nye JS, Fishell G. Radial glial identity is promoted by Notch1 signaling in the murine forebrain. Neuron 2000, 26(2):395-404. 10.1016/S0896-6273(00)81172-1, 10839358.
48. Ge W, Martinowich K, Wu X, He F, Miyamoto A, Fan G, Weinmaster G, Sun YE. Notch signaling promotes astrogliogenesis via direct CSL-mediated glial gene activation. J Neurosci Res 2002, 69(6):848-860. 10.1002/jnr.10364, 12205678.
49. Givogri MI, Costa RM, Schonmann V, Silva AJ, Campagnoni AT, Bongarzone ER. Central nervous system myelination in mice with deficient expression of Notch1 receptor. J Neurosci Res 2002, 67(3):309-320. 10.1002/jnr.10128, 11813235.
50. Lutolf S, Radtke F, Aguet M, Suter U, Taylor V. Notch1 is required for neuronal and glial differentiation in the cerebellum. Development 2002, 129(2):373-385.
51. Patten BA, Peyrin JM, Weinmaster G, Corfas G. Sequential signaling through Notch1 and erbB receptors mediates radial glia differentiation. J Neurosci 2003, 23(14):6132-6140.
52. Weller M, Krautler N, Mantei N, Suter U, Taylor V. Jagged1 ablation results in cerebellar granule cell migration defects and depletion of Bergmann glia. Dev Neurosci 2006, 28(1-2):70-80. 10.1159/000090754, 16508305.
53. Lopez SL, Paganelli AR, Siri MV, Ocana OH, Franco PG, Carrasco AE. Notch activates sonic hedgehog and both are involved in the specification of dorsal midline cell-fates in Xenopus. Development 2003, 130(10):2225-2238. 10.1242/dev.00443, 12668635.
54. Corrales JD, Blaess S, Mahoney EM, Joyner AL. The level of sonic hedgehog signaling regulates the complexity of cerebellar foliation. Development 2006, 133(9):1811-1821. 10.1242/dev.02351, 16571625.